Comparable endotoxic properties of lipopolysaccharides are manifest in diverse clinical isolates of gram-negative bacteria

Infection and Immunity

Volumn 68, Issue 4, 2000, Pages 1899-1904

  Luchi, Michael ^a   Morrison, David C ^b  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b Office of Medical Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; ENDOTOXIN;

ANIMAL CELL; ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOKINE RELEASE; ENDOTOXEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPSIS; STRAIN DIFFERENCE; STRUCTURE ANALYSIS;

ANIMALS; CITROBACTER; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ESCHERICHIA COLI; GALACTOSAMINE; GRAM-NEGATIVE BACTERIA; LETHAL DOSE 50; LIMULUS TEST; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; PROTEUS MIRABILIS; SERRATIA MARCESCENS; SILVER STAINING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034104816     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.4.1899-1904.2000     Document Type: Article

References (35)

1. Ames, B. N., and D. T. Dubin. 1960. The role of polyamines in the neutralization of bacteriophage deoxyribonucleic acid. J. Biol. Chem. 235:769-775.
2. Amura, C. R., R. Silverstein, and D. C. Morrison. 1998. TI: mechanisms involved in the pathogenesis of sepsis are not necessarily reflected by in vitro cell activation studies. Infect. Immun. 66:5372-5378.
3. Arditi, M., W. Kabat, and R. Yogev. 1993. Antibiotic-induced bacterial killing stimulates tumor necrosis factor-alpha release in whole blood. J. Infect. Dis. 167:240-244.
4. Brandtzaeg, P., T. E. Mollnes, and P. Kierulf. 1989. Complement activation and endotoxin levels in systemic meningococcal disease. J. Infect. Dis. 160: 58-65.
5. Bucklin, S. E., and D. C. Morrison. 1995. Differences in therapeutic efficacy among cell wall-active antibiotics in a mouse model of gram-negative sepsis. J. Infect. Dis. 172:1519-1527.
6. Dofferhoff, A. S., M. T. Esselink, H. G. de Vries Hospers, A. van Zanten, V. J. Bom, J. Weits, and E. Vellenga. 1993. The release of endotoxin from antibiotic-treated Escherichia coli and the production of tumour necrosis factor by human monocytes. J. Antimicrob. Chemother. 31:373-384.
7. Doran, T. I. 1999. The role of citrobacter in clinical disease of children: review. Clin. Infect. Dis. 28:384-394.
8. Edmond, M. B., S. E. Wallace, D. K. McClish, M. A. Pfaller, R. N. Jones, and R. P. Wenzel. 1999. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin. Infect. Dis. 29:239-244.
9. Elin, R. J., R. A. Robinson, A. S. Levine, and S. M. Wolff. 1975. Lack of clinical usefulness of the limulus test in the diagnosis of endotoxemia. N. Engl. J. Med. 293:521-524.
10. Galanos, C., M. A. Freudenberg, T. Katschinski, R. Salomao, H. Mossmann, and Y. Kumazawa. 1992. Tumor necrosis factor and host response to endotoxin, p. 75-104. In J. L. Ryan and D. C. Morrison (ed.), Bacterial endotoxic lipopolysaccharides: immunopharmacology and pathophysiology. CRC, Ann Arbor, Mich.
11. Galanos, C., M. A. Freudenberg, and W. Reutter. 1979. Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc. Natl. Acad. Sci. USA 76:5939-5943.
12. Goodman, G. W., and B. M. Sultzer. 1979. Endotoxin protein is a mitogen and polyclonal activator of human B lymphocytes. J. Exp. Med. 149:713-723.
13. Hurley, J. C. 1992. Antibiotic-induced release of endotoxin: a reappraisal. Clin. Infect. Dis. 15:840-854.
14. Ingalls, R. R., H. Heine, E. Lien, A. Yoshimura, and D. Golenbock. 1999. Lipopolysaccharide recognition, CD14, and lipopolysaccharide receptors. Infect. Dis. Clin. North Am. 13:341-353.
15. Jackson, J. J., and H. Kropp. 1992. Beta-lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime. J. Infect. Dis. 165:1033-1041.
16. Jackson, J. J., and H. Kropp. 1996. Differences in mode of action of β-lactam antibiotics influence morphology, LPS release and in vivo antibiotic efficacy. J. Endotoxin. Res. 3:201-218.
17. Karkhanis, Y. D., J. Y. Zeltner, J. J. Jackson, and D. J. Carlo. 1978. A new and improved microassay to determine 2-keto-3-deoxyoctonate in lipopolysaccharide of gram-negative bacteria. Anal. Biochem. 85:595-601.
18. Killion, J. W., and D. C. Morrison. 1988. Determinants of immunity to murine salmonellosis: studies involving immunization with lipopolysaccharide-lipid A-associated protein complexes in C3H/HeJ mice. FEMS Microbiol. Immunol. 1:41-53.
19. Levin, J., T. E. Poore, N. S. Young, S. Margolis, N. P. Zauber, A. S. Townes, and W. R. Bell. 1972. Gram-negative sepsis: detection of endotoxemia with the limulus test, with studies of associated changes in blood coagulation, serum lipids, and complement. Ann. Intern. Med. 76:1-7.
20. Levin, J., T. E. Poore, N. P. Zauber, and R. S. Oser. 1970. Detection of endotoxin in the blood of patients with sepsis due to gram-negative bacteria. N. Engl. J. Med. 283:1313-1316.
21. Manthey, C. L., and S. N. Vogel. 1994. Elimination of trace endotoxin protein from rough chemotype LPS. J. Endotoxin Res. 1:84-89.
22. Morrison, D. C., S. J. Betz, and D. M. Jacobs. 1976. Isolation of a lipid A bound polypeptide responsible for "LPS-initiated" mitogenesis of C3H/HeJ spleen cells. J. Exp. Med. 144:840-846.
23. Morrison, D. C., and L. Leive. 1975. Fractions of lipopolysaccharide from Escherichia coli O111B:4 prepared by two extraction procedures. J. Biol. Chem. 250:2911-2919.
24. Morrison, D. C., S. W. Vukajlovich, J. L. Ryan, and J. Levin. 1987. Structural requirements for gelation of the Limulus amebocyte lysate by endotoxin. Prog. Clin. Biol. Res. 231:55-73.
25. Pfaller, M. A., R. N. Jones, S. A. Marshall, S. L. Coffman, R. J. Hollis, M. B. Edmond, and R. P. Wenzel. 1997. Inducible ampC beta-lactamase producing gram-negative bacilli from blood stream infections: frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE). Diagn. Microbiol. Infect. Dis. 28:211-219.
26. Rangel-Frausto, M. S. 1999. The epidemiology of bacterial sepsis. Infect. Dis. Clin. North Am. 13:299-312.
27. Reed, L. J., and H. Muench. 1938. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 27:493-497.
28. Rudbach, J. A., F. I. Akiya, R. J. Elin, H. D. Hochstein, M. K. Luoma, E. C. Milner, K. C. Milner, and K. R. Thomas. 1976. Preparation and properties of a national reference endotoxin. J. Clin. Microbiol. 3:21-25.
29. Simon, D. M., G. Koenig, and G. M. Trenholme. 1991. Differences in release of tumor necrosis factor from THP-1 cells stimulated by filtrates of antibiotic-killed Escherichia coli. J. Infect. Dis. 164:800-802.
30. Stumacher, R. J., M. J. Kovnat, and W. R. McCabe. 1973. Limitations of the usefulness of the Limulus assay for endotoxin. N. Engl. J. Med. 288:1261-1264.
31. Tsai, C. M., and C. E. Frasch. 1982. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal. Biochem. 119:115-119.
32. van der, P. T., and S. J. van Deventer. 1999. Cytokines and anticytokines in the pathogenesis of sepsis. Infect. Dis. Clin. North Am. 13:413-426.
33. Vukajlovich, S. W., and D. C. Morrison. 1985. Activation of murine spleen cells by lipid A: negative modulation of lipid A mitogenic activity by O-antigen polysaccharide. J. Immunol. 135:2546-2550.
34. Westphal, O., and K. Jann. 1965. Bacterial lipopolysaccharides: extraction with phenol-water and further applications of the procedure, p. 83-91. In R. L. Whistler (ed.), Methods in carbohydrate chemistry. Academic Press. Inc., New York, N.Y.
35. Westphal, O., O. Luderitz, and F. Bister. 1952. Über die Extraktion von Bakterien mit Phenol/Wasser. Z. Naturforschung. B 7B:148-155.